110 likes | 187 Views
About Quro Pipeline Organization News Contact. Home Site Map. INNOVATION IN INFECTIOUS DISEASES TREATMENT. About Quro Pipeline Organization News Contact. Home Site Map. Quro Science Inc.
E N D
About Quro Pipeline Organization News Contact Home Site Map INNOVATION IN INFECTIOUS DISEASES TREATMENT
About Quro Pipeline Organization News Contact Home Site Map Quro Science Inc. Quro is a spin-off biotechnology company from Institut Pasteur Korea (IP-K) committed to develop novel therapeutics against infectious diseases. Quro’s main focus is on human immunodeficiency virus (HIV), hepatitis C virus (HCV) and tuberculosis (TB) infection. Quro has exclusive rights to develop and commercialize drug candidates discovered with IP-K’s proprietary state-of-the-art technologies including the PhenomicScreenTM and PhenomicIDTM platforms. Quro has in-house expertise in preclinical and clinical development management and operates as a virtual company using contract research organizations (CROs) for execution of the development works. Quro intends to license out the products in the course of the clinical development to larger partners for further development.
About Quro Pipeline Organization News Contact Home Site Map Quro’s Operations Model
About Quro Pipeline Organization News Contact Home Site Map
About QuroPipeline Organization News Contact Home Site Map
About Quro Pipeline Organization News Contact Home Site Map Organizational Chart
About Quro Pipeline Organization News Contact Home Site Map Management Team Dr. Ulf Nehrbass, CEO Dr. Nehrbass graduated in Biochemistry from Cambridge University, UK, and obtained his Ph.D. at the EMBL in Heidelberg, Germany in 1992. After a postdoctoral position in the Howard Hughes Medical Institute at the Rockefeller University, New York, he joined the Institut Pasteur in Paris, in 1998 where he was Head of the Nuclear Cell Biology unit and CNRS Research Director. After a number of research awards he was elected member of EMBO in 2005. He has been CEO of IP-Korea since its inception in 2004.
About Quro Pipeline Organization News Contact Home Site Map Board of Directors Dr. Ulf Nehrbass Head of the Nuclear Cell Biology unit, Institut Pasteur in Paris CNRS Research Director CEO of Institut Pasteur Korea Dr. Yung Bog ChaeChairman of Institut Pasteur Korea Board of Directors Chairman of Gyeonggi Bio-Center Former Minister, Ministry of Science and Technology, Republic of Korea Mr. Seok Won YoonGeneral Manager, Hanwha Venture Capital Corp. Director, Green & Biotech, Inc. General Manager, Basic Venture Capital, Co., Ltd
About Quro Pipeline Organization News Contact Home Site Map Board of Directors Dr. Yongmo Lee Director, Center for International Cooperation, National Research Foundation Associate Professor, Dr. Myung Whan Park Director of Gyeonggi Bio-Center External Auditor Dr. Jae Whan Park Professor, Department of Business and Management School Of Social Science, Chung-Ang University
About Quro Pipeline Organization News Contact Home Site Map Bulletin board here
About Quro Pipeline Organization News Contact Home Site Map Quro Science Inc. Sampyeong-dong 696 Bundang-gu Seongnam-si Gyeonggi-do, Korea Tel: +82-31-8018-8370 Fax: +82-31-8018-8380 info@quroscience.com